Alphatec Spine posted first quarter revenue of $49.7 million, which is a 40.9 percent increase over the first quarter of 2010. The company’s success is attributable to a boost in sales from PureGen and FDA clearance of the Solus anterior lumbar interbody fusion system.
ArthroCare posted first quarter revenue of $87.9 million, representing a 1.3 percent decrease from the same quarter last year. The company’s sports medicine product sales slumped during this quarter, decreasing from $60 million in the first quarter of 2010 to $56.7 million during the same 2011 period.
Biomet reported a 1 percent increase in net sales, to $678 million, during the third quarter of the fiscal year 2011. The company also announced a net loss of $11.6 million during the third quarter as well as a 5 percent decrease in U.S. knee sales and flat U.S. hip sales.
BioMimetic Therapeutics posted $83.7 million in cash, cash equivalents and investments, while also experiencing $8 million in net losses during the first quarter. The company expects its revenue to grow when its Augment Bone Graft, which was recently recommended by the FDA medical advisory panel, receives FDA premarket approval.
DePuy Orthoapedics reported $811 million in sales during the first quarter of 2011, a 7.2 percent increase over the first quarter of last year. Johnson & Johnson, DePuy’s parent company, reported $271 million in expenses from litigation and additional DePuy ASR Hip recall costs.
DJO Global reports net sales of $249.7 million in the first quarter, which is an increase from last year’s first quarter report of $240.1 million. The company’s success was driven by the net sales of its science’s division, at $85.1 million, and the surgical implant segment contributed $15.5 million to overall net sales.
Exactech reported $53.4 million in first quarter revenue, a 9 percent increase over the first quarter of last year. The company experienced a 33 percent increase in extremities implant revenue, which was reported as $9.4 million, and a 21 percent increase in hip implant revenue, reported as $21.3 million.
MAKO Surgical posted first quarter revenue of $13 million, an 80 percent increase over the same period in 2010. The company’s success can be contributed to a 78 percent increase in MAKOplasty procedures performed, totaling 1,304 during the three month period.
Orthofix posted net sales of $139.2 million and a net loss of $35.8 million during the first quarter of 2011. The company took a $43 million charge to anticipate resolving criminal and civil matters, and as still able to report a slight increase from the $138.8 million in net sales reported during the first quarter of last year.
Stryker reported net sales of $2 billion during the first quarter, a 10.2 percent increase over the same period last year. Despite the increase, its knee sales decreased by 2 percent and its hip sales increased by 2 percent.
Symmetry Medical reported first quarter revenue of $95.8 million, which is a 13 percent increase over the first quarter of last year. The company’s success was driven by its instrument business, contributing $39.2 million to the overall revenue, which is a 24 percent increase over last year.
TranS1 reported $5.1 million in first quarter revenues, which is a 24 percent decrease over last year. The company attributes to decline in revenue to decreasing reimbursements for physicians who use its AxiaLIF, but two critical papers are set for publishing in peer review journals that could prompt higher reimbursement in the future.
Wright Medical Group reported first quarter net sales of $135.4 million, a 3 percent increase over the net sales of the first quarter last year. The company’s sales were driven by hip products, accounting for $45.9 million, followed by knee products, accounting for $32.8 million.
Zimmer reported $1.1 billion in nets sales for the first quarter, a 5 percent increase compared to the first quarter of 2010. The company’s success was driven by its reconstructive products, contributing $842 million from worldwide sales.
Related Articles on Orthopedic Device Companies:
20 of the Most Profitable Orthopedic and Spine Device Companies
42 Orthopedic and Spine Device Companies to Know
35 Orthopedic and Spine Device Companies Receive FDA 510(k) Clearance in April
